US 10130651
RNAi Therapy for Hepatitis B Virus Infection
granted A61KA61K31/713A61K38/16
Quick answer
US patent 10130651 (RNAi Therapy for Hepatitis B Virus Infection) held by Arrowhead Pharmaceuticals, Inc. expires Mon Nov 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Arrowhead Pharmaceuticals, Inc.
- Grant date
- Tue Nov 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K31/713, A61K38/16, A61K47/549, A61K47/554